Ignite Creation Date:
2024-05-06 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 12:45 PM
Study NCT ID:
NCT03517956
Status:
COMPLETED
Last Update Posted:
2022-07-14
First Post:
2018-05-03
Brief Title:
Phase 1 Study of the Combination of Rogaratinib With Copanlisib in Patients With Fibroblast Growth Factor Receptor FGFR-Positive Locally Advanced or Metastatic Solid Tumors
Sponsor:
Bayer
Organization:
Bayer